<DOC>
	<DOCNO>NCT01656512</DOCNO>
	<brief_summary>Acute Lymphoblastic Leukemia ( ALL ) common malignancy child . It account one fourth childhood cancer &amp; 74 % childhood leukemia . Based upon drug registry data , child prescribe three course systemic glucocorticoid yearly face 20 % increase age-adjusted fracture rate . Rapid recovery occur glucocorticoid discontinue , fracture rate return expect age 1 year treatment ( Journal Of Clinical Endocrinology &amp; Metabolism 2009 ) . The investigator study role bisphosphonates prevention secondary osteoporosis child &amp; adolescent treat ALL Children 's Cancer Hospital -Egypt .</brief_summary>
	<brief_title>Zometa Study Pediatric Acute Lymphoblastic Leukemia</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Age 5 &amp; 18 year time diagnosis . Newly diagnose ALL patient . Not previously treat , previous steroid intake 72 hour . Treated accord St Judy study XV protocol . Previous steroid intake 72 hour . Less 5 year</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>ALL</keyword>
	<keyword>zoledronic acid</keyword>
	<keyword>Osteoporosis</keyword>
</DOC>